Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2500-2503

  Rouprêt, Morgan ^a,b,c,d,g,j   Cancel Tassin, Géraldine ^b,g   Comperat, Eva ^c,d,g   Fromont, Gaëlle ^b,f,g   Sibony, Mathilde ^c,d,g   Molinié, Vincent ^e   Allory, Yves ^g   Triau, Stéphane ^h   Champigneulle, Jacqueline ⁱ   Gaffory, Cécile ^b,g   Larré, Stéphane ^b   De La Taille, Alexandre ^g   Richard, François ^c,d   Hamdy, Freddie C ^a   Cussenot, Olivier ^b,c,d,g  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL TENON   (France)

^e SAINT JOSEPH HOSPITAL   (France)

^f UNIVERSITÉ DE POITIERS   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h UNIVERSITÉ D'ANGERS   (France)

ⁱ CHU NANCY BRABOIS   (France)

^j ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYL SULFOTRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; GENDER; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYLSULFOTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 38849177330     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0361     Document Type: Article

References (24)

1. Kogevinas M, t Mannetje A, Cordier S, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 2003;14:907-14.
2. Olgac S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 2004;28:1545-52.
3. Laing C, Hamour S, Sheaff M, Miller R, Woolfson R. Chinese herbal uropathy and nephropathy. Lancet 2006;368:338.
4. Linet MS, Chow WH, McLaughlin JK, et al. Analgesics and cancers of the renal pelvis and ureter. Int J Cancer 1995;62:15-8.
5. Roupret M, Catto J, Coulet F, et al. Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma. J Med Genet 2004;41:e91.
6. Pereira WO, Paiva AS, Queiroz JW, et al. Genetic polymorphism in the sulfotransferase SULT1A1 gene in cancer. Cancer Genet Cytogenet 2005;160:55-60.
7. Bamber DE, Fryer AA, Strange RC, et al. Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 2001;11:679-85.
8. Zheng L, Wang Y, Schabath MB, Grossman HB, Wu X. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett 2003;202:61-9.
9. Hung RJ, Boffetta P, Brennan P, et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004;110:598-604.
10. Tsukino H, Kuroda Y, Nakao H, et al. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol 2004;130:99-106.
11. Catto JW, Azzouzi AR, Amira N, et al. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 2003;22:8699-706.
12. Catto JW, Azzouzi AR, Rehman I, et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 2005;23:2903-10.
13. Puente D, Hartge P, Greiser E, et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control 2006;17:71-9.
14. Roupret M, Fromont G, Azzouzi AR, et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 2005;65:1233-7.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Coughtrie MW, Gilissen RA, Shek B, et al. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 1999;337:45-9.
17. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
18. Boccia S, Cadoni G, La Torre G, et al. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J Cancer Res Clin Oncol 2006;132:466-72.
19. Ozawa S, Katoh T, Inatomi H, et al. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population. Int J Cancer 2002;102:418-21.
20. Pachouri SS, Sobti RC, Kaur P, Singh J, Gupta SK. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. Cancer Genet Cytogenet 2006;171:39-43.
21. Liang FX, Bosland MC, Huang H, et al. Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol 2005;171:835-44.
22. Gamage NU, Duggleby RG, Barnett AC, et al. Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 2003;278:7655-62.
23. Nowell S, Falany CN. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 2006;25:1673-8.
24. Gross M, Kruisselbrink T, Anderson K, et al. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomarkers Prev 1999;8:683-92.